The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
Recap by typeshit. Post by Facebook on Facebook.
KTSM breaks down which Medicare enrollees are eligible for GLP-1 drugs at a $50 monthly cost.
Men's Journal looks at the extra spending that comes with GLP-1 drugs beyond the prescription price, as these meds reshape weight loss.
The Times reports plans that could put Wegovy on Ireland's public health service, a potential shift in who can get the drug without paying privately.
Fifteen drugs, from Ozempic and Wegovy to Trelegy Ellipta, get Medicare negotiated prices that take effect January 1, 2027.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
Loading…